2019 Analytical Chemistry Clinical Development Licensing 
Drug Discovery World
MARCH 7, 2023
She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. See her interview with Megan Thomas at the Avacta Group Open Day.
The Pharma Data
NOVEMBER 5, 2020
Prior to joining Imperative Care in 2019, Davis served as chief commercial officer and president of North America at Penumbra, Inc., Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Before GSK, Rosén was senior vice president, U.S.
Expert insights. Personalized for you.
246 
Let's personalize your content